Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer.
about
Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancerPre-operative chemoradiation for non-metastatic locally advanced rectal cancerPreoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancerPre-operative radiotherapy and curative surgery for the management of localized rectal carcinomaRadiotherapy for Colorectal Cancer: Current Standards and Future PerspectivesNeoadjuvant chemoradiation therapy and pathological complete response in rectal cancerCurrent treatment of rectal cancer adapted to the individual patientEvolving treatment strategies for colorectal cancer: a critical review of current therapeutic optionsNeoadjuvant chemotherapy without radiotherapy for locally advanced rectal cancerRectal cancer: An evidence-based update for primary care providersCurrent debate in the oncologic management of rectal cancer.A comparison of dosimetric parameters between tomotherapy and three-dimensional conformal radiotherapy in rectal cancerNeoadjuvant treatment for rectal cancer-A value-based proposition.Use of adjuvant chemotherapy in stage C (III) rectal cancer: comparison of data from matched patients in a teaching hospital's clinico-pathological database.Changes in treatment patterns for patients with locally advanced rectal cancer in the United States over the past decade: An analysis from the National Cancer Data Base.Preoperative short-course radiotherapy versus combined radiochemotherapy in locally advanced rectal cancer: a multi-centre prospectively randomised study of the Berlin Cancer Society.A prospective phase II study of magnetic resonance imaging guided hematopoietical bone marrow-sparing intensity-modulated radiotherapy with concurrent chemotherapy for rectal cancer.Efficacy and safety of neoadjuvant chemotherapy with oxaliplatin, 5-fluorouracil, and levofolinate for T3 or T4 stage II/III rectal cancer: the FACT trial.Pre-operative hyperfractionated concurrent radiochemotherapy for locally advanced rectal cancers: a phase II clinical study.Prospective phase II study of preoperative short-course radiotherapy for rectal cancer with twice daily fractions of 2.9 Gy to a total dose of 29 Gy--long-term resultsPreoperative Radiotherapy Is Not Associated with Increased Post-mastectomy Short-term Morbidity: Analysis of 77,902 Patients.Neoadjuvant therapy before surgical treatmentThe modern anatomical surgical approach to localised rectal cancer.Neoadjuvant vs adjuvant pelvic radiotherapy for locally advanced rectal cancer: Which is superior?Rectal cancer level significantly affects rates and patterns of distant metastases among rectal cancer patients post curative-intent surgery without neoadjuvant therapy.Effects of change in rectal cancer management on outcomes in British Columbia.Avoiding radical surgery after pre-operative chemoradiotherapy: a possible therapeutic option in rectal cancer?Multidisciplinary treatment of rectal cancer in 2014: where are we going?Overview of radiation therapy for treating rectal cancer.Long-term results of a randomized trial in locally advanced rectal cancer: no benefit from adding a brachytherapy boost.Therapeutic approaches in the management of locally advanced rectal cancer.The emerging role of neoadjuvant chemotherapy for rectal cancerAdjuvant chemoradiotherapy of advanced resectable rectal cancer: results of a randomised trial comparing modulation of 5-fluorouracil with folinic acid or with interferon-α.Preoperative chemoradiation and extended pelvic lymphadenectomy for rectal cancer: Two distinct principles.Adjuvant therapy sparing in rectal cancer achieving complete response after chemoradiation2010 SSO John Wayne clinical research lecture: rectal cancer outcome improvements in Europe: population-based outcome registrations will conquer the worldInitial results of a randomized controlled trial comparing clinical and pathological downstaging of rectal cancer after preoperative short-course radiotherapy or long-term chemoradiotherapy, both with delayed surgery.Sphincter preservation for distal rectal cancer--a goal worth achieving at all costs?Neoadjuvant radiotherapy for rectal cancer: meta-analysis of randomized controlled trials.Impact of KRAS, BRAF and PI3KCA mutations in rectal carcinomas treated with neoadjuvant radiochemotherapy and surgery.
P2860
Q24200568-F5D6C606-B127-4D8B-8239-ADCEB29E8C76Q24202425-E61344AC-B693-476D-B175-2AD3471C285AQ24241258-E918BB1C-8EB1-429A-B6FA-0DB67F8ECF29Q24245030-2427F662-CEDE-4876-BBDC-C9CE83A4FBE9Q26738806-24E85A1E-BF96-43BF-AF10-B93C79754E65Q26796352-2B831911-221B-45EE-8F19-2A44967DECA5Q26824553-A42320C0-0641-46E5-ABB4-593884DC281FQ26998617-610874F8-38A9-4DE4-8626-93860BE48A95Q27003878-B9C2EA90-5FA5-4CAB-8952-1CCA78A5F320Q27013068-A13FD91B-E41A-486D-9E77-E85BFA5A8BD0Q28072948-5B70EE20-70B7-4CC1-826E-BC2C0F003A6CQ28294759-1746A1AC-0309-4C88-BC01-1C0F629AB71FQ30251516-58FCD57E-B35A-4481-B13A-87B522CD6C7CQ30557842-42D91277-E615-4EF1-8785-9BBCDCECCFF8Q31076178-C2BAB678-FEA7-4E63-8BB3-001C1A3EFFA9Q33406632-36053E11-CB81-4BB2-BE3F-CDFCDE8A1ADFQ33427911-E5AC4A0D-C9D0-4715-AF73-4AA39C89FC59Q33438899-1CB520B3-90F2-4405-B9C2-F9570CE84C26Q33441568-BC6C0FCF-1EE8-4543-B2A4-969B6F75AAEFQ33589855-C7BFC35E-BB28-46CF-BB91-39A968ADA6EAQ33601499-1012689C-028F-48F3-9D52-4E1AEC21935AQ33697924-40A5CFA7-6076-4DA1-851D-70B78D26A04DQ33698397-73BBC164-ADB2-4A9D-B1FB-DD8C5F028DF6Q33849039-DA963D76-5EC1-4D08-92E8-43EE3C3BD802Q33942156-3ABECDD4-32CF-45CC-BCB0-DD763D829709Q34027979-8383BE1F-190B-4368-8CFC-9B7BF895FCA7Q34093710-658E7AA4-A300-4E8D-A63D-49F5050C9CD5Q34093825-19867833-8131-41CF-A2A9-372109773122Q34136267-288262B5-1A70-4099-81F6-DB23C95A99F9Q34156692-9DC23F16-D78F-47C6-8243-AE3C2000E9BBQ34234928-063011D4-A41B-402C-AFC2-EF608C487B1FQ34234935-4AF73EB8-E6D3-4EF9-928F-9C5D87951745Q34255956-A2ECAA15-1FFA-4BEF-9AB9-1D10FD3D1FE0Q34391360-83A94FD0-A1C7-4CEF-B9B4-A3D61E368045Q34499179-12930055-B507-4301-8FA0-BF6C72CBEA87Q34601597-AE2DD1FF-8D5C-437A-8F60-FCE246B45844Q34632095-54FD258D-9B4F-45CA-8F95-83A3E03160C1Q34635027-57E0117C-9F12-407F-A8D4-7AE43E9B24F4Q34655838-15143DB8-3B70-4DEA-BD87-7D425C402084Q34687101-E44AB77F-75D0-4C0A-8DBC-AE0850798B61
P2860
Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer.
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Long-term results of a randomi ...... moradiation for rectal cancer.
@ast
Long-term results of a randomi ...... moradiation for rectal cancer.
@en
Long-term results of a randomi ...... moradiation for rectal cancer.
@nl
type
label
Long-term results of a randomi ...... moradiation for rectal cancer.
@ast
Long-term results of a randomi ...... moradiation for rectal cancer.
@en
Long-term results of a randomi ...... moradiation for rectal cancer.
@nl
prefLabel
Long-term results of a randomi ...... moradiation for rectal cancer.
@ast
Long-term results of a randomi ...... moradiation for rectal cancer.
@en
Long-term results of a randomi ...... moradiation for rectal cancer.
@nl
P2093
P356
P1476
Long-term results of a randomi ...... moradiation for rectal cancer.
@en
P2093
Michalski W
Nasierowska-Guttmejer A
Nowacki MP
P304
P356
10.1002/BJS.5506
P407
P577
2006-10-01T00:00:00Z